Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11561 |
HIF-2α-IN-2
|
HIF/HIF Prolyl-Hydroxylase; HIF | Angiogenesis; Chromatin/Epigenetic; Metabolism |
HIF-2α-IN-2 是低氧诱导因子抑制剂,IC50=16 nM。 | |||
T15482 |
HIF-2α-IN-1
|
HIF | Angiogenesis; Chromatin/Epigenetic |
HIF-2α-IN-1是一种有效的 HIF-2α 抑制剂, IC50值小于500 nM。 | |||
T67831 |
HIF-2α agonist 2
|
HIF/HIF Prolyl-Hydroxylase; HIF | Angiogenesis; Chromatin/Epigenetic; Metabolism |
HIF-2α agonist 2 是一种 HIF-2α 激动剂,对HIF-2α的EC50 值为 1.68 μM。HIF-2α agonist 2可以促进HIF-2a-ARNT 复合物3z 结构中ARNT A/B 环的稳定性, 对 786-O-HRE-Luc 细胞无细胞毒性。HIF-2α agonist 2可用于氧代谢研究,与癌症的发生密切相关。 | |||
T11562 |
HIF-2α-IN-3
|
HIF | Angiogenesis; Chromatin/Epigenetic |
HIF-2α-IN-3 is an allosteric inhibitor of HIF-2α (IC50: 0.4 μM; KD: 1.1 μM) with anticancer activity. | |||
T50099 |
HIF-2α-IN-4
|
Others; HIF/HIF Prolyl-Hydroxylase | Chromatin/Epigenetic; Metabolism; Others |
HIF-2a translation inhibitor 是一种有效的HIF-2α翻译抑制剂,IC50=5 μM,能够抑制组成型和缺氧诱导的 HIF-2α 蛋白表达。其中 HIF-2α-IN-4 将 5'UTR 铁响应元件与氧传感联系起来。 | |||
T36711 |
FM19G11
FM19G11,HIF-1alpha/2alpha Inhibitor |
HIF | Angiogenesis; Chromatin/Epigenetic |
FM19G11 是一种低氧诱导因子 (HIF) α-亚基抑制剂(在低氧诱导的荧光素酶试验中 IC50 为 80 nM)。 | |||
T29797 |
AKB-6899
AKB6899 |
VEGFR; HIF/HIF Prolyl-Hydroxylase; HIF | Angiogenesis; Chromatin/Epigenetic; Metabolism; Tyrosine Kinase/Adaptors |
AKB-6899 是脯氨酰羟化酶结构域 3 (PHD3) 的抑制剂,可增加 GM-CSF 处理的巨噬细胞产生的 VEGF 受体的可溶形式 (sVEGFR-1)。 AKB-6899 能稳定 HIF-2α,从而诱导肿瘤相关巨噬细胞产生 sVEGFR-1 并减少肿瘤生长。 | |||
T0692 |
Allopurinol
Zyloric,别嘌醇,Zyloprim,Lopurin,别嘌呤醇 |
ROS; Xanthine Oxidase | Immunology/Inflammation; Metabolism |
Allopurinol (Zyloric) 是一种黄嘌呤氧化酶(XO)抑制剂,IC50=7.82±0.12 μM。 | |||
T6376 |
Allopurinol Sodium
1H-吡唑并[3,4-D]嘧啶-4-醇单钠盐,Allopurinol sodium salt,Sodium allopurinol |
ROS | Immunology/Inflammation |
Allopurinol Sodium 是黄嘌呤氧化酶抑制剂,其IC50= 0.2~50 μM。它能够抗利什曼原虫,也可用于研究痛风以及高尿酸血症。 | |||
T72997 |
HIF-2α-IN-7
|
||
HIF-2α-IN-7 是一种缺氧诱导因子 2α(HIF-2α)抑制剂。HIF-2α-IN-7 抑制 HIF-2α,EC50值为 6 nM。HIF-2α-IN-7 可用于多种疾病的研究,包括癌症、肝病、炎性疾病、肺病和铁负荷紊乱。 | |||
T61367 |
HIF-2α-IN-6
|
||
HIF-2α-IN-6 (117) 是HIF-2α的抑制剂。 | |||
T61614 |
HIF-2α-IN-5
|
||
HIF-2α-IN-5 是一种有效的 HIF-2α的抑制剂,IC50小于 50 nM。 | |||
T78937 | HIF-2α-IN-9 | HIF/HIF Prolyl-Hydroxylase | Chromatin/Epigenetic; Metabolism |
HIF-2α-IN-9(compound 35r)为HIF-2α抑制剂,能够抑制VEGF-A(IC50=305 nM),影响肿瘤细胞生长基因表达并促进巨噬细胞介导的肿瘤免疫反应。 | |||
T61442 | HIF-1/2α-IN-1 | ||
HIF-1/2α-IN-1, an orally active compound, functions as an inhibitor of HIF-2α. Its inhibitory effect on HIF-2α activity is significant, with an IC 50 value of 0.92 μM. Furthermore, HIF-1/2α-IN-1 has the ability to decrease HIF-1α levels. This compound is particularly valuable for research on clear cell renal cell carcinoma (ccRCC) [1]. | |||
T61102 |
HIF-1/2α-IN-2
|
||
HIF-1/2α-IN-2 is a potent inhibitor of HIF-1/2α, which effectively reduces the levels of HIF-1/2α. This compound elicits an iron starvation response by specifically targeting ISCA2, a key protein involved in Iron Sulfur Cluster Assembly 2. [1] | |||
T12675L |
PT2399
|
HIF/HIF Prolyl-Hydroxylase; HIF | Angiogenesis; Chromatin/Epigenetic; Metabolism |
PT2399 是高选择性的HIF-2α拮抗剂,能直接结合 HIF-2α PAS B 结构域,IC50=6 nM,具有显著的体内抗肿瘤特性。 | |||
T17009 |
TC-S 7009
|
HIF | Angiogenesis; Chromatin/Epigenetic |
TC-S 7009是一种有效的和具有选择性的HIF-2α抑制剂(Kd: 81 nM)。TC-S 7009对HIF-2α的亲和力大于HIF-1α (Kd >> 5 μM)。 TC-S 7009破坏HIF-2α异源二聚化,降低HIF-2α靶基因表达,降低dna 结合活性。 | |||
T7848 |
PT-2385
|
HIF/HIF Prolyl-Hydroxylase; HIF | Angiogenesis; Chromatin/Epigenetic; Metabolism |
PT-2385 是一种选择性HIF-2α抑制剂,Ki< 50 nM。 | |||
T7802 |
M1001
|
HIF/HIF Prolyl-Hydroxylase; HIF | Angiogenesis; Chromatin/Epigenetic; Metabolism |
M1001 是较弱的HIF-2α激动剂,直接与 HIF-2α PAS-B 结构域结合,Kd=667 nM,能够提高 HIF-2α-ARNT 复合体之间的稳定性。 | |||
T16679 |
Belzutifan
PT2977,MK-6482 |
HIF | Angiogenesis; Chromatin/Epigenetic |
Belzutifan (MK-6482) 是具有口服活性的 HIF-2α选择性抑制剂,IC50为 9 nM。Belzutifan 具有提高的效力和改善的药代动力学特征。Belzutifan (MK-6482) 可以抑制透明细胞肾细胞癌。 | |||
T12675 |
(Rac)-PT2399
|
HIF | Angiogenesis; Chromatin/Epigenetic |
(Rac)-PT2399 is a potent and specific inhibitor of hypoxia-inducible factor 2a (HIF-2α)(IC50 of 0.01 μM). | |||
T69080 |
T1001
|
||
T1001 is an antagonist of hypoxia-inducible factor-2α subunit (HIF-2α) which displaces residue M252 from inside the HIF-2α PAS-B pocket toward the ARNT subunit to weaken heterodimerization. | |||
T6804 |
Chetomin
Chaetomin,NSC289491,BRN0077366 |
Apoptosis; HSP; HIF | Angiogenesis; Apoptosis; Chromatin/Epigenetic; Cytoskeletal Signaling; Metabolism |
Chetomin (BRN0077366) 是球毛壳菌的活性成分,是一种无毒的非小细胞肺癌干细胞靶向分子。它是一种热休克蛋白90/缺氧诱导因子1α 途径的抑制剂。 | |||
TP2046 |
TAT-cyclo-CLLFVY
|
||
Selective HIF-1 dimerization inhibitor. Blocks protein-protein interaction of recombinant HIF-1α, but not HIF-2α, with HIF-1β (IC50 = 1.3 μM). Inhibits hypoxia-induced HIF-1 activity, and decreases VEGF and CAIX expression in osteosarcoma and breast cance | |||
T36492 | CMC2.24 | ||
CMC2.24 (TRB-N0224) is an orally active tricarbonylmethane agent that demonstrates effectiveness in inhibiting Ras activation and the downstream effector ERK1/2 pathway, thus effectively combating pancreatic tumor formation in mice. Additionally, CMC2.24 exerts potent inhibitory effects on zinc-dependent MMPs, with IC50s ranging from 2.0-69 μM. Furthermore, CMC2.24 aids in alleviating the progression of osteoarthritis by restoring cartilage homeostasis and inhibiting chondrocyte apoptosis throug... | |||
T69966 |
Roxadustat-d5
|
||
Roxadustat-d5 is intended for use as an internal standard for the quantification of roxadustat by GC- or LC-MS. Roxadustat is an inhibitor of hypoxia-inducible factor prolyl hydroxylase (HIF-PH; IC50s = 1.4, 1.26, and 1.32 µM for HIF-PH1, HIF-PH2, and HIF-PH3, respectively). It is selective for HIF-PH over other 2-oxoglutarate-dependent dioxygenases, including lysine-specific demethylase 5A (KDM5A), KDM5B, -5C, -5D, and -6B (IC50s = >100 µM for all). Roxadustat (10-200 µM) stabilizes HIF-1α and ... |